Nostrum Biodiscovery (NBD) is a pioneering company specializing in computational drug discovery services. NBD leverages cutting-edge in silico technologies to assist biopharmaceutical and biotechnology companies, Contract Research Organizations (CROs), and academic institutions in rational drug discovery, enzyme engineering, and nucleic acids research. The company operates in the highly specialized market of computational biology and drug design, providing essential tools and expertise that streamline the drug development process. NBD's business model revolves around offering bespoke computational solutions and collaborative projects, generating revenue through service contracts and partnerships. Notably, NBD has formed a strategic alliance with ENAMINE to develop a high-performance search engine for the REAL Space billion database, enhancing the efficiency of chemical space exploration. This collaboration underscores NBD's commitment to innovation and excellence in the field of drug discovery.

Keywords: computational drug discovery, in silico technologies, biopharmaceutical, biotechnology, CROs, enzyme engineering, nucleic acids, molecular dynamics, drug design, chemical space exploration.